GVS stimulation coupled with inverse phase rotatory chair stimulation at sinusoidal harmonic acceleration protocol
ProcedureGVS stimulation coupled with inverse phase rotatory chair stimulation at sinusoidal harmonic acceleration protocol
NCT Number: NCT05004818
subjects with severe seasickness, who failed to habituate to sea conditions after at least six month of active sailing, were enrolled to the single-blind randomized control study. The intervention group was treated with rotatory chair stimulation at sinusoidal harmonic acceleration protocol coupled with galvanic vestibular stimulation to the mastoid processes. This unique procedure was hypothesized to promote habituation to seasickness. The control group underwent a sham procedure. All study participants filled out seasickness questionnaires at set time points following the intervention and underwent repeated step testing to determine their vestibular time constant. The number of anti-motion sickness clinic visits and scopolamine prescriptions was also recorded in the three months period following the intervention.
Looking for future studies?
Notify Me19 year–44 year
Male
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
GVS stimulation coupled with inverse phase rotatory chair stimulation at sinusoidal harmonic acceleration protocol
Participants with severe motion sickness were sited in the the rotatory chair with the videonystagmography recorder masking their eyes, while two galvanic vestibular stimulation electrodes were connected to the mastoid processes. No active stimulus was given.
Time frame: Until one month following the intervention
Vestibular time constant was measured using repeated rotatory chair stimulation in step protocol.
Time frame: Until one month following the intervention
Seasickness severity as determined by Wiker questionnaire at set time frames following the intervention
Time frame: Until three months following the intervention
scopolamine drug prescriptions were calculated for each participant and compared between the two groups
Time frame: Until three months following the intervention
Anti-motion sickness clinic visits were calculated for each participant and compared between the two groups
Medical Corps, Israel Defense Force
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06587386
Motion Sickness, Pathological Conditions, Signs and Symptoms
Jiaxing, China
View Trial DetailsNCT04999449
Motion Sickness, Pathological Conditions, Signs and Symptoms
Lebanon, New Hampshire, United States
View Trial DetailsNCT06354309
Amblyopia, Brain Diseases
Shenyang, Liaoning, China
View Trial DetailsNCT03772340
Motion Sickness, Pathological Conditions, Signs and Symptoms
Santa Monica, California, United States
View Trial Details